Journal article · 2024 · Open access

Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics

Riccardo Rampado, Gonna Somu Naidu, Olga Karpov, Meir Goldsmith, Preeti Sharma, Assaf Ezra, Lior Stotsky‐Oterin, Dor Breier, Dan Peer

Advanced Science, 12(3), e2408744 · Published 25 November 2024 · DOI 10.1002/advs.202408744

Open full textCite this paper

In brief

“Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics” is a 2024 journal article by Riccardo Rampado and 8 co-authors, published in Advanced Science. OpenAlex counts 40 citations as of 21 November 2026, which puts it in the top 1% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Advanced Science.

Citations
40
Most cited in
2025 (21)
Field-weighted impact
3.82
References
57
Authors
9

Abstract

Lipid Nanoparticles (LNPs) recently emerged as an invaluable RNA delivery platform. With many LNP-based therapeutics in the pre-clinical and clinical pipelines, there is extensive research dedicated to improving LNPs. These efforts focus mainly on the tolerability and transfectability of new ionizable lipids and RNAs, or modulating LNPs biodistribution with active targeting strategies. However, most formulations follow the well-established lipid proportions used in clinically approved products. Nevertheless, investigating the effects of LNPs composition on their biodistribution can expand the toolbox for particle design, leading to improved delivery strategies. Herein, a new LNPs (30-n-LNPs) formulation with increasing amounts of phospholipids is investigated as a possible mRNA delivery system for treating Inflammatory Bowel Diseases. Compared to LNPs with benchmark composition (b-LNPs), n-LNPs containing 30% distearoylphosphatidylcholine (DSPC) are well tolerated following intravenous administration and display natural targeting toward the inflamed colon in dextran sodium sulfate (DSS)-colitis bearing mice, while de-targeting clearing organs such as the liver and spleen. Using interleukin-10-encoding mRNA as therapeutic cargo, n-LNPs demonstrated a reduction of pathological burden in colitis-bearing mice. n-LNPs represent a starting point to further investigate the influence of LNPs composition on systemic biodistribution, ultimately opening new therapeutic modalities in different pathologies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Rampado, R., Naidu, G. S., Karpov, O., Goldsmith, M., Sharma, P., Ezra, A., Stotsky‐Oterin, L., Breier, D., & Peer, D. (2024). Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics. Advanced Science, 12(3), e2408744. https://doi.org/10.1002/advs.202408744

MLA 9

Rampado, Riccardo, et al. “Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics.” Advanced Science, vol. 12, no. 3, 2024, p. e2408744. https://doi.org/10.1002/advs.202408744.

Chicago

Rampado, Riccardo, Gonna Somu Naidu, Olga Karpov, Meir Goldsmith, Preeti Sharma, Assaf Ezra, Lior Stotsky‐Oterin, Dor Breier, and Dan Peer. 2024. “Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics.” Advanced Science 12 (3): e2408744. https://doi.org/10.1002/advs.202408744.

Harvard

Rampado, R. et al. (2024) ‘Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics’, Advanced Science, 12(3), p. e2408744. doi:10.1002/advs.202408744.

IEEE

R. Rampado et al., “Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics,” Advanced Science, vol. 12, no. 3, p. e2408744, 2024, doi: 10.1002/advs.202408744.

BibTeX

@article{rampado2024lipid,
  title     = {{Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics}},
  author    = {Rampado, Riccardo and Naidu, Gonna Somu and Karpov, Olga and Goldsmith, Meir and Sharma, Preeti and Ezra, Assaf and Stotsky‐Oterin, Lior and Breier, Dor and Peer, Dan},
  journal   = {Advanced Science},
  year      = {2024},
  volume    = {12},
  number    = {3},
  pages     = {e2408744},
  doi       = {10.1002/advs.202408744},
  url       = {https://doi.org/10.1002/advs.202408744}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • lipid nanoparticles
  • mRNA delivery
  • colon targeting
  • phospholipid content
  • distearoylphosphatidylcholine
  • tissue distribution
  • inflammatory bowel disease
  • DSS-induced colitis

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Rampado, R., Naidu, G. S., Karpov, O., Goldsmith, M., Sharma, P., Ezra, A., Stotsky‐Oterin, L., Breier, D., & Peer, D. (2024). Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics. Advanced Science, 12(3), e2408744. https://doi.org/10.1002/advs.202408744

How many times has this paper been cited?

40 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Advanced Science: sign in and open the full text from this page.

Who wrote this paper?

Riccardo Rampado, Gonna Somu Naidu, Olga Karpov, Meir Goldsmith, Preeti Sharma, Assaf Ezra, Lior Stotsky‐Oterin, Dor Breier, Dan Peer.

What is the DOI of this paper?

10.1002/advs.202408744, permanently at https://doi.org/10.1002/advs.202408744. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.